Skip to content

Released Nov 6, 2012

10-Q filed Nov 6, 2012, 37 days after period end · 0001104659-12-074731

Q3 2012 · 10-Q
Revenue$96.41M+689.1% vs Q3 2011+560.2% vs Q2 2012
Net Income$47.64MN/M vs Q3 2011no prior Q2 2012 on file
EPS Diluted$0.42N/M vs Q3 2011N/M vs Q2 2012
Operating Income$47,608,000N/M
Operating Cash Flowderived$38,995,000N/M
Free Cash Flowderived$35,437,000N/M
Margins · derived
Operating margin49.4%+226.3 pt vs Q3 2011
Net margin49.4%+218.3 pt vs Q3 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2012Q3 2011Q3 2010
Revenue$96.41M$12.22M$9.06M
Net Income$47.64M-$20.63M-$6.75M
EPS Diluted$0.42-$0.21-$0.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR